主编精选:腹主动脉瘤腔内治疗及年病例量影响——德国血管外科与血管医学学会质量登记研究
该研究基于德国多中心质量登记数据,回顾性分析2017年1月至2023年12月间194个中心共19641例腹主动脉瘤腔内修复术(EVAR)患者,其中完整AAA 18763例、破裂AAA 878例。多因素回归显示年病例量及严重慢性肾衰竭与完整AAA修复后院内死亡无关,而ASA评分≥4、近肾动脉瘤、严重心衰、女性、较大动脉瘤直径、高龄及癌症、慢阻肺、卒中史与院内死亡相关。
要点
- 年EVAR病例量中位数34.7例,25.1%患者在高病例量中心(高于第75百分位)治疗。
- 完整AAA修复后院内死亡率1.0%,破裂AAA为19.7%。
- 年病例量对完整AAA修复后院内死亡无显著影响,仅对任何术后并发症复合终点有统计学显著影响(p = .008)。
核心结论
- 该大型登记分析未能证实病例量对完整AAA的EVAR短期结果有影响。
- 未来研究应关注EVAR长期结局以及小直径AAA治疗比例相当大的原因。
研究设计与样本
- 回顾性观察性研究,基于德国多中心质量登记数据,纳入2017年1月至2023年12月间194个中心因完整或破裂AAA行EVAR的19641例患者(女性2576例,占13.1%;中位年龄74岁,四分位距68、80)。
- 完整AAA 18763例,破裂AAA 878例;采用多因素逻辑回归模型分析年病例量及危险因素对院内死亡、并发症率及救治失败的影响。
主要发现
- 完整AAA修复后中位住院6天(IQR 5、8),院内死亡率1.0%,任何术后并发症率8.2%。
- 破裂AAA修复后中位住院10天(IQR 6、17),院内死亡率19.7%,任何术后并发症率31.4%。
- 完整AAA病例完成血管造影时内漏发生率17.6%(II型14.5%),破裂AAA为18.2%(II型11.0%)。
- 中心年EVAR病例量中位数34.7例(IQR 22.1、58.4),25.1%患者在高病例量中心(高于第75百分位)治疗。
- ASA评分≥4、近肾动脉瘤、严重心衰、女性、较大动脉瘤直径、高龄及癌症、慢阻肺、卒中史与完整AAA修复后院内死亡相关,年病例量和严重慢性肾衰竭不相关。
关键数值与推荐
- 44.3%男性以最大直径<55 mm、31.8%女性以<50 mm接受治疗。
- 年病例量对任何术后并发症复合终点有统计学显著影响(p = .008),对院内死亡无显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: While the impact of annual caseload on short term outcomes after abdominal aortic aneurysm (AAA) repair remains under debate, current data from the most decentralised healthcare system in Europe may offer valuable insights into an area that has changed considerably due to the widespread use of endovascular aortic aneurysm repair (EVAR). METHODS: This was a retrospective observational study of multicentre quality registry data from Germany on EVAR for intact and ruptured AAA between January 2017 and December 2023. The impact of annual caseload and risk factors on in hospital death, complication rates, and failure to rescue after intact AAA repair was determined using multivariable logistic regression models. RESULTS: A total of 19 641 individuals (n = 2 576 females [13.1%]; median age 74 years, interquartile range [IQR] 68, 80) who underwent EVAR for intact (n = 18 763) or ruptured (n = 878) AAA were included from 194 centres. Among these, 44.3% of males were selected for treatment with a maximum diameter < 55 mm (31.8% of females < 50 mm). After a median length of hospital stay of six days (IQR 5, 8) and 10 days (IQR 6, 17) for intact and ruptured cases, 1.0% and 19.7% died, respectively. The rate of any post-interventional complication was 8.2% and 31.4%, respectively. An endoleak was apparent on the completion angiogram in 17.6% of intact cases (14.5% type II) and 18.2% of ruptured cases (11.0% type II). The median annual EVAR caseload per centre was 34.7 (IQR 22.1, 58.4), and 25.1% of patients were treated at centres above the 75th percentile. An American Society of Anesthesiologists (ASA) score ≥ 4, juxtarenal aneurysm extent, severe heart failure, female sex, larger aneurysm diameter, older age, and history of cancer, chronic obstructive pulmonary disease, and stroke were associated with in hospital death after intact AAA repair, but annual caseload and severe chronic kidney failure were not. Sensitivity analyses including different outcomes were confirmative, except for a statistically significant impact of annual caseload on the composite endpoint of any post-interventional complication (p = .008). CONCLUSION: This large registry analysis was unable to confirm an impact of caseload on short term results after EVAR for intact AAA. Future studies should address long term outcomes after EVAR as well as the underlying reasons for the considerably large proportion of small diameter AAA treatment.
引用
- Besch A, Heckenkamp J, Adili F, et al. Editor's Choice - Endovascular Treatment of Abdominal Aortic Aneurysm and Impact of Annual Caseload in the Quality Registry of the German Society for Vascular Surgery and Vascular Medicine (DGG). Eur J Vasc Endovasc Surg. 2025. PMID: 40354966. doi:10.1016/j.ejvs.2025.05.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。